HTLV-1 and Adult T-Cell Leukemia/Lymphoma: A Review

References

• Takatsuki, K., Uchiyama, T., Sagawa, K. and Yodoi, J. (1977). Adult T cell leukemia in Japan. In: Seno, S., Takaku, F. and Imino, S. Eds. Topics in hematology. Amsterdam: Excerpta Medica, pp. 73–7.
   Google Scholar
• Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K. and Uchino, H. (1977). Adult T cell leukemia: clinical and hematologic features of 16 cases. Blood, 50, 481–492.
   PubMed Web of Science ®Google Scholar
• Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F. et al. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA, 77, 7415–7419.
   PubMed Web of Science ®Google Scholar
• Hinuma, Y., Nagata, K., Hanaoka, M. et al. (1981). Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA, 78, 6476–6480.
   PubMed Web of Science ®Google Scholar
• Yoshida, M., Seiki, M., Yamaguchi, K. and Takatsuki, K. (1984). Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc. Natl. Acad. Sci. USA, 81, 2534–2537.
   PubMed Web of Science ®Google Scholar
• Gessain, A. and Gout, O. (1992). Chronic myelopathy associated with HTLV-1. Ann. Intern. Med., 177, 933–946.
   Google Scholar
• Ijichi, S., Nakagawa, M., Umehara, F., Higuchi, I. et al. (1996). HAM/TSP: recent perspectives in Japan. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 13, Suppl 1, S26–S32.
   PubMedGoogle Scholar
• Osame, M., Arimura, K., Nakagawa, M., Umehara, F., Usuku, K. and Ijichi, S. (1997). HTLV-1 associated myelopathy (HAM): review and recent studies. Leukemia, 11,: Suppl 3: 63–4.
   PubMedGoogle Scholar
• Kalden, J. R. and Gay, S. (1994). Retroviruses and autoimmune rheumatic diseases. Clin. Exp. Immunol., 98, 1–5.
   PubMed Web of Science ®Google Scholar
• McCallum, R. M., Patel, D. D., Moore, J. O. and Haynes, B. E. (1997). Arthritis syndromes associated with human T cell lymphotropic virus type I infection. Med. Clin. North. Am, 81, 261–276.
   PubMed Web of Science ®Google Scholar
• Greenl, J. E., Hinrichs, S. H., Vogel, J. and Jay, G. (1989). Exocrinopathy resembling Sjogren's syndrome in HTLV-I transgenic mice. Nature, 34, 172–174.
   Google Scholar
• Kompoliti, A., Gage, B., Sharma, L. and Daniels, J. C. (1996). Human T-cell lymphotropic virus type 1-associated myelopathy, Sjogren's syndrome and lymphocytic pneumonitis. Arch. Neurol., 53, 940–942.
   PubMedGoogle Scholar
• Wiley, C. A., Nerenberg, M., Cros, D. and Soto-Aguilar, M. (1989). HTLV-1 polymyositis in a patient also infected with the human immuno-deficiency virus. N. Engl. J. Med., 320, 992–995.
   PubMed Web of Science ®Google Scholar
• Sagawa, K., Mochizuki, M., Masuoka, K. et al. (1995). Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-1) uveitis. J. Clin. Invest, 95, 852–858.
   PubMed Web of Science ®Google Scholar
• Couderc, L. J., Caubarrere, I. and Venet, A. et al. (1988). Bronchoalveolar lymphocytosis in patients with tropical spastic paraparesis associated with human T-cell lymphotropic virus type 1. Ann. Intern. Med., 109, 625–628.
   PubMed Web of Science ®Google Scholar
• Grenade, L. L. (1996). HTLV-I-associated infective dermatitis: past, present, and future. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 13, Suppl 1, S46–S49.
   PubMedGoogle Scholar
• Weber, T., Hunsmann, G., Stevens, W., Fleming, A. F. (1992). Human retroviruses. Baillieres. Clin. Haematol, 5, 273–314.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, K. and Takatsuki, K. (1993). Adult T cell leukaemia-lymphoma. Baillieres. Clin. Haematol., 6, 899–915.
   PubMed Web of Science ®Google Scholar
• Harrington, W. J., Ucar, A., Gill, P. et al. (1995). Clinical spectrum of HTLV-1 in south Florida. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 8, 466–473.
   PubMedGoogle Scholar
• Takatsuki, K., Matsuoka, M. and Yamaguchi, K. (1996). Adult T-cell leukemia in Japan. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 13, Suppl 1, S15–S19.
   PubMedGoogle Scholar
• Hanchard, B. (1996). Adult T-cell leukemia/lymphoma in Jamaica: 1986–1995. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol, 13, Suppl 1, S20–S25.
   PubMedGoogle Scholar
• Soriano, V., Gutierrez, M., Vallejo, A., Aguilera, A., Calderon, E. and Escudero, D. (1995). HTLV-1-associated illnesses in Spain. Vox Sang, 69, 261–262.
   PubMed Web of Science ®Google Scholar
• Taylor, G. P. (1996). The epidemiology of HTLV-1 in Europe. J. Acquir. immune. Defic. Syndr. Hum. Retrovirol., 13, Suppl 1, S8–S14.
   PubMedGoogle Scholar
• Veelken, H., Kohler, G., Schneider, J. et al. (1996). HTLV-1-associated adult T cell leukemia/lymphoma in two patients from Bucharest, Romania. Leukemia, 10, 1366–1369.
   PubMed Web of Science ®Google Scholar
• Gascoyne, R. D., Kim, S. M., Oger, J. J. F., Melosky, B. L. and Dekaban, G. A. (1996). HTLV-1 associated adult T cell leukemia/lymphoma: report of two cases from an Amerindian population in coastal northwest British Columbia. Leukemia, 10, 552–557.
   PubMed Web of Science ®Google Scholar
• Pawson, R., Mufti, G. J. and Pagliuca, A. (1998). Management of adult T-cell leukemia/lymphoma. Br. J. Haematol, 100, 453–458.
   PubMed Web of Science ®Google Scholar
• Andrade, T. M., Dourado, I., Galvao-Castro, B. et al. (1998). Associations among HTLV-I, HTLV-II and HIV in injecting drug users in Salvador, Brazil. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol, 18, 186–187.
   PubMedGoogle Scholar
• Flier, J. S. and Underhill, L. H. (1993). Pathogenesis of diseases induced by HTLV-1 infection. N. Engl. J. Med., 328, 1173–1182.
   PubMed Web of Science ®Google Scholar
• Ackermann, H. W., Berthiaume, L. and Tremblay, M. Eds. (1998). Virus life in diagrams: chapter 6 viruses with reverse transcription. Boca Raton: CRC Press, 115–136.
   Google Scholar
• Davey, F. R. and Hutchison, R. E. (1991). Pathology and immunology of adult T-cell leukemia/lymphoma. Curr. Opin. Oncol., 3, 13–20.
   PubMedGoogle Scholar
• Lyons, S. F. and Liebowitz, D. N. (1998). The roles of human viruses in the pathogenesis of lymphoma. Semin. Oncol., 25, 461–475.
   PubMed Web of Science ®Google Scholar
• Franchini, G. and Streicher, H. (1995). Human T-cell leukemia virus. Baillieres. Clin. Haematol., 8, 131–148.
   PubMed Web of Science ®Google Scholar
• Rosenblatt, J. D., Miles, S., Gasson, J. C. and Prager, D. (1995). Transactivation of cellular genes by human retroviruses. Curr. Top. Microbiol. Immunol., 193, 25–49.
   PubMed Web of Science ®Google Scholar
• Yoshida, M. (1996). Molecular biology of HTLV-I: recent progress. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol, 13, Suppl 1, S63–S68.
   PubMedGoogle Scholar
• Grossman, W. J. and Ratner, L. (1996). Transgenic mouse models for HTLV-1 infection. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol, 13, Suppl 1, S162–S169.
   PubMedGoogle Scholar
• Uchiyama, T. (1997). Human T cell leukemia virus type 1 (HTLV-1) and human diseases. Annu. Rev. Immunol, 15, 15–37.
   PubMed Web of Science ®Google Scholar
• Seiki, M., Eddy, R., Shows, T. B. and Yoshida, M. (1984). Nonspecific integration of the HTLV provirus genome into adult T-cell leukemia cells. Nature, 309, 640–642.
   PubMed Web of Science ®Google Scholar
• Ozden, S., Coscoy, L. and Gonzalez-Dunia, D. (1996). HTLV-I transgemic models: an overview. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 13, Suppl 1, S154–S161.
   PubMedGoogle Scholar
• Nerenberg, M., Xu, X. and Brown, D. A. (1996). Transgenic models of HTLV-1 mediated disease and latency. Curr. Top. Microbiol. Immunol., 206, 175–196.
   PubMed Web of Science ®Google Scholar
• Uchiyama, T. (1996). ATL and HTLV-I: in vivo cell growth of ATL cells. J. Clin. Immunol, 16, 305–314.
   PubMed Web of Science ®Google Scholar
• Mori, N. and Proger, D. (1997). Transactivation of the interleukin-1 alpha promoter by human T-cell leukemia virus. Leuk. Lymphoma, 26, 421–433.
   PubMed Web of Science ®Google Scholar
• Hiscott, J., Beauparlant, P., Crepieux, P. et al. (1997). Cellular and viral protein interactions regulating IkBα activity during human retrovirus infection, J. Leukoc. Biol., 62, 82–92.
   PubMed Web of Science ®Google Scholar
• Yoshida, M. (1997). Molecular biology of HTLV-1: deregulation of host cell gene expression and cell cycle. Leukemia, 11, Suppl 3, 1–2.
   PubMed Web of Science ®Google Scholar
• Ferreira, O. C. Jr., Planelles, V. and Rosenblatt, J. D. (1997). Human T-cell leukemia viruses: epidemiology, biology and pathogenesis. Blood Rev., 11, 91–104.
   PubMed Web of Science ®Google Scholar
• Nicot, C., Tie, F. and Giam, C.-Z. (1998). Cytoplasmic forms of human T-cell leukemia virus type 1 Tax induce NF-kB activation. J. Virol., 72, 6777–6784.
   PubMed Web of Science ®Google Scholar
• Geleziunas, R., Ferrell, S., Lin, X. et al. (1998). Human T-cell leukemia virus type 1 Tax induction of NF-kB involves activation of the IkB kinaseα (IKKα) and IKKβ cellular kinases. Mol. Cell. Biol., 18, 5157–5165.
   PubMed Web of Science ®Google Scholar
• Ballard, D. W., Bohnlein, E., Lowenthal, J. W., Wano, Y., Franza, B. R. and Greene, W. C. (1988). HTLV-1 tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science, 241, 1652–1655.
   PubMed Web of Science ®Google Scholar
• Leung, K. and Nabel, G. J. (1988). HTLV-1 trans-activation induces interleukin-2 receptor expression through an NF-kB-like factor. Nature, 333, 776–778.
   PubMed Web of Science ®Google Scholar
• Screck, R. and Bauerle, P. (1990). NF-kB as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Mol. Cell. Biol., 10, 1281–1286.
   PubMed Web of Science ®Google Scholar
• Buckle, G. J., Hafler, D. A. and Hollsberg, P. (1996). HTLV-1-induced T-cell activation. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol, 13, Suppl 1, S107–S113.
   PubMedGoogle Scholar
• Mori, N. and Proger, D. (1996). Transactivation of the interleukin-1α promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood, 87, 3410–3417.
   PubMed Web of Science ®Google Scholar
• Nakamura, M., Takasawa, N., Ohbo, K. et al. (1997). HTLV-I Tax trans-activation and cell growth signaling. Leukemia, 11, Suppl 3, S7–S9.
   PubMedGoogle Scholar
• Mori, N., Gill, P. S., Mougdil, T., Murakami, S., Eto, S. and Proger, D. (1996). Interleukin-10 gene expression in adult T-cell leukemia. Blood, 88, 1035–1045.
   PubMed Web of Science ®Google Scholar
• Gram, C. Z. and Xu, Y. L. (1989). HTLV-1 Tax gene product activates transcription via pre-existing cellular factors and cAMP responsive element. J. Biol. Chem., 264, 15236–15241.
   PubMed Web of Science ®Google Scholar
• Suzuki, T., Fujisawa, J. I., Toita, M. and Yoshida, M. (1993). The transactivator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE moderator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc. Natl. Acad. Sci. USA, 90, 610–614.
   PubMed Web of Science ®Google Scholar
• Prager, D., Rosenblatt, J. D. and Ejima, E. (1994). Hypercalcemia, parathyroid hormone-related protein expression and human T-cell leukemia virus infection. Leuk. Lymphoma, 14, 395–400.
   PubMed Web of Science ®Google Scholar
• Suzuki, T., Kitao, S., Matsushime, H. and Yoshida, M. (1996). HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. Embo. J., 15, 1607–1614.
   PubMed Web of Science ®Google Scholar
• Jeang, K. T., Widen, S. G., Semmes IV, O. J. and Wilson, S. H. (1990). HTLV-1 trans-activator protein, Tax, is a trans-repressor of the human beta-polymerase gene. Science, 247, 1082–1084.
   PubMed Web of Science ®Google Scholar
• Ishibashi, K., Ishitsuka, K., Chuman, Y. et al. (1991). Tumor necrosis factor-β in the serum of adult T-cell leukemia with hypercalcemia. Blood, 77, 2451–2455.
   PubMed Web of Science ®Google Scholar
• Copeland, K. F. T. and Heeney, J. L. (1996). T helper cell activation and human retroviral pathogenesis. Microbiol. Rev., 60, 722–742.
   PubMedGoogle Scholar
• Imura, A., Hori, T., Imada, K. et al. (1997). Ox 40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: implication for the possible involvement of Ox 40 in leukemic cell infiltration. Blood, 89, 2951–2958.
   PubMed Web of Science ®Google Scholar
• Mori, N. and Prager, D. (1998). Interleukin-10 gene expression and adult T-cell leukemia. Leuk. Lymphoma, 29, 239–248.
   PubMed Web of Science ®Google Scholar
• Murphy, E. L., Hanchard, B., Figueroa, J. P. et al. (1989). Modeling the risk of adult T-cell leukemia/lymphoma in persons affected with human T-lymphotropic virus type I. Int. J. Cancer, 43, 250–253.
   PubMed Web of Science ®Google Scholar
• Kondo, T., Kono, H., Miyamoto, N. et al. (1989). Age-and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int. J. Cancer, 43, 1061–1064.
   PubMed Web of Science ®Google Scholar
• Pombo, de Oliveira, Matutes, E., Schulz, T. et al. (1995). T-cell malignancies in Brazil: clinico-pathological and molecular studies of HTLV-1-positive and -negative cases. Int. J. Cancer, 60, 823–827.
   PubMed Web of Science ®Google Scholar
• Lin, B. T.-Y., Musset, M., Szekely, A. M. et al. (1997). Human T-cell lymphotropic virus-1-positive T-cell leukemia/lymphoma in a child. Arch. Pathol. Lab. Med., 121, 1282–1286.
   PubMed Web of Science ®Google Scholar
• Funai, N., Shimamoto, Y., Yoshida, S.-I., Nagai, Y., Nakazato, S. and Kohashi, O. (1996). Differences in immune functions between human T-lymphotropic virus type 1 carriers and patients with adult T-cell leukemia/lymphoma. Clin. Immunol. Immunopathol., 80, 325–332.
   PubMedGoogle Scholar
• Lymphoma Study Group (1984–1987). (1991) Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Leuk. Res., 15, 81–90.
   Google Scholar
• Matutes, E. and Catovsky, D. (1991). Mature T-cell leukemia and leukemia/lymphoma syndromes. Leuk. Lymphoma, 4, 81–91.
   PubMed Web of Science ®Google Scholar
• Setoyama, M., Mizoguchi, S. and Kanzaki, T. (1998). Prurigo as a clinical prodrome to adult T-cell leukemia/lymphoma. Br. J. Dermatol., 138, 137–140.
   PubMed Web of Science ®Google Scholar
• Setoyama, M., Yamamoto, S. and Kanzaki, T. (1997). Adult T-cell leukemia/lymphoma presenting with digital gangrene. Dermatology, 195, 150–152.
   PubMed Web of Science ®Google Scholar
• Yamada, Y., Kamihira, S., Murata, K. et al. (1997). Frequent hepatic involvement in adult T cell leukemia: comparison with non-Hodgkin's lymphoma. Leuk. Lymphoma, 26, 327–335.
   PubMed Web of Science ®Google Scholar
• Takatsuki, K., Matsuoka, M. and Yamaguchi, K. (1994). ATL and HTLV-I-related diseases. In: Takatsuki, K. Ed. Adult T-cell leukemia. Oxford: Oxford University Press, pp. 1–27.
   Google Scholar
• Watanabe, T., Yamaguchi, K., Takatsuki, K., Osame, M. and Yoshida, M. (1990). Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene. J. Exp. Med., 172, 759–765.
   PubMed Web of Science ®Google Scholar
• White, J. D., Zaknoen, S. L., Kasten-Sportes, C. et al. (1995). Infectious complications and immunodeficiency in patients with human T-cell lymphotropic virus I-associated adult T-cell leukemia/lymphoma. Cancer, 75, 1598–1607.
   PubMed Web of Science ®Google Scholar
• Shimoyama, M. and members of the Lymphoma Study Group (1984–87). (1991). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Br. J. Haematol., 79, 428–437.
   Web of Science ®Google Scholar
• Tachibana, N., Okayama, A., Ishizaki, J. et al. (1988). Suppression of tuberculin skin reaction in healthy HTLV-1 carriers from Japan. Int. J. Cancer, 42, 829–831.
   PubMed Web of Science ®Google Scholar
• Newton, R. C., Limpuangthip, P., Greenberg, S., Gain, A. and Neva, F. A. (1992). Strongyloides stercoralis hyperinfection in a carrier of HTLV-1 virus with evidence of selective immunosuppression. Am. J. Med., 92, 202–208.
   PubMed Web of Science ®Google Scholar
• Rhew, D. C., Gaultier, C. R., Daar, E. S., Zakowski, P. C. and Said, J. (1995). Infections in patients with chronic adult T-cell leukemia/lymphoma: case report and review. Clin. Infect. Dis., 21, 1014–1016.
   PubMed Web of Science ®Google Scholar
• Plumelle, Y., Gonin, C., Edouard, A. et al. (1997). Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T cell leukemia. Am. J. Clin. Pathol., 107, 81–87.
   PubMed Web of Science ®Google Scholar
• Del Giudice, P., Marie, D. S., Gerard, Y., Couppie, P. and Pradinaud, R. (1997). Is crusted (Norwegian) scabies a marker of adult T cell leukemia/lymphoma in human T lymphotropic virus type I-seropositive patients? J. Infect. Dis., 176, 1090–1092.
   PubMed Web of Science ®Google Scholar
• Sakata, H., Fujimoto, K., Iwakiri, R. et al. (1996). Gastric lesions in 76 patients with adult T-cell leukemia/lymphoma. Cancer, 78, 396–402.
   PubMed Web of Science ®Google Scholar
• Shibata, K., Shimamoto, Y., Nishimura, T., Okinami, S., Yamada, H. and Miyahara, M. (1997). Ocular manifestations in adult T-cell leukemia/lymphoma. Ann. Hematol., 74, 163–168.
   PubMed Web of Science ®Google Scholar
• Takemoto, S., Matsuoka, M., Sakata, K. et al. (1996). Primary adult T cell leukemia of bone: two patients with primary bone lesion showing monoclonal integration of HTLV-I proviral DNA. Leukemia, 10, 333–337.
   PubMed Web of Science ®Google Scholar
• Daisley, H. and Charles, W. (1997). Cardiac involvement with lymphoma/leukemia: a report of three autopsy cases. Leukemia, 11, Suppl 3, 522–524.
   PubMedGoogle Scholar
• Shimamoto, Y. and Yamaguchi, M. (1992). HTLV-1 induced extranodal lymphoma. Leuk. Lymphoma, 7, 37–45.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, K., Nishimura, H., Kohrogi, H., Jono, M., Miyamoto, Y. and Takatsuki, K. (1983). A proposal for smoldering adult T-cell leukemia: a clinicopathologic study of five cases. Blood, 62, 758–766.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, K., Seiki, M., Yoshida, M., Nishimura, H., Kawano, F. and Takatsuki, K. (1984). The detection of human T cell leukemia virus proviral DNA and its application for classification and diagnosis of T cell malignancy. Blood, 63, 1235–1240.
   PubMed Web of Science ®Google Scholar
• Kawano, F., Yamaguchi, K., Nishmura, H., Tsuda, H. and Takatsuki, K. (1985). Variation in the clinical courses of adult T-cell leukemia. Cancer, 55, 851–856.
   PubMed Web of Science ®Google Scholar
• Matutes, E. and Catovsky, D. (1994). ATL of Caribbean origin. In: Takatsuki, K. Ed. Adult T-cell leukemia. Oxford: Oxford University Press, pp. 113–138.
   Google Scholar
• Ohshima, K., Suzumiya, J., Sato, K. et al. (1998). Nodal T-cell lymphoma in an HTLV-I-endemic area: proviral HTLV-I DNA, histological classification and clinical evaluation. Br. J. Haematol., 101, 703–711.
   PubMed Web of Science ®Google Scholar
• Sanada, I., Tanak, R., Kumagai, E. et al. (1985). Chromosomal aberrations in adult T cell leukemia: relationship to the clinical severity. Blood, 65, 649–654.
   PubMed Web of Science ®Google Scholar
• Kamada, N., Sakurai, M., Miyamoto, K. et al. (1992). Chromosomal abnormalities in adult T-cell leukemia/lymphoma: a karyotype review committee report. Cancer. Res., 52, 1481–1493.
   PubMed Web of Science ®Google Scholar
• Sadamori, N. (1991). Cytogenetic implication in adult T-cell leukemia. Cancer. Genet. Cytogenet., 51, 131–136.
   PubMed Web of Science ®Google Scholar
• Ness, P. M. and Nass, C. C. (1994). Blood donor testing for HIV-I/II and HTLV-I/II. Arch. Pathol. Lab. Med., 118, 337–341.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, K., Matsuoka, M., Takemoto, S., Tamiya, S., Etoh, K. and Takatsuki, K. (1996). DNA diagnosis of HTLV-1. Intervirology, 39, 158–164.
   PubMed Web of Science ®Google Scholar
• Courouce, A.-M., Pillonel, J., Lemaire, J.-M. and Saura, C. (1998). HTLV testing in blood transfusion. Vox. Sang., 74, Suppl 2, 165–169.
   PubMed Web of Science ®Google Scholar
• Kamahira, S., Sohda, H., Atogami, S. et al. (1992). Phenotypic diversity and prognosis of adult T-cell leukemia. Leuk. Res., 16, 435–441.
   PubMed Web of Science ®Google Scholar
• Shimamoto, Y., Miyahara, M., Yamada, H., Shibata, K., Matsuzaki, M. and Ono, K. (1996). Adult T-cell leukemia/lymphoma with multiple integrations of human T-cell lymphotropic virus type I proviral DNA: differing clinical features are linked to varied proviral integration. Br. J. Haematol., 92, 632–638.
   PubMed Web of Science ®Google Scholar
• Shimamoto, Y. (1997). Clinical indications of multiple integrations of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma. Leuk. Lymphoma, 27, 43–51.
   PubMed Web of Science ®Google Scholar
• Yamamura, M., Yamada, Y., Momita, S., Kamihira, S. and Tomonaga, M. (1998). Circulating interleukin-6 levels are elevated in adult T-cell leukemia/lymphoma patients and correlate with adverse clinical features and survival. Br. J. Haematol., 100, 129–134.
   PubMed Web of Science ®Google Scholar
• Shimayama, M. (1994). Chemotherapy of ATL. In: Takatsuki, K. Ed. Adult T-cell leukemia. Oxford: Oxford University Press, pp. 221–237.
   Google Scholar
• Uozumi, K., Hanada, S., Ohno, N. et al. (1995). Combination chemotherapy (RCM protocol: response oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia. Leuk. Lymphoma, 18, 317–323.
   PubMed Web of Science ®Google Scholar
• Taguchi, H., Kinoshita, K. I., Takatsuki, K. et al. (1996). An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 12, 182–186.
   PubMedGoogle Scholar
• Hanada, S., Utsunomiya, A., Suzuki, S., Uozumi, K., Makino, T. and Arima, T. (1997). Treatment for adult T-cell leukemia. Cancer Chemother. Pharmacol., 40, Suppl, S47–S50.
   PubMed Web of Science ®Google Scholar
• Wang, J., Kobayashi, M., Sakurada, K., Imamura, M., Moriuchi, T. and Hosokawa, M. (1997). Possible roles of an adult T-cell leukemia (ATL)-derived factor/thioredoxin in the drug resistance of ATL to adriamycin. Blood, 89, 2480–2487.
   PubMed Web of Science ®Google Scholar
• Uozumi, K., Nakahara, K., Takatsuka, Y. et al. (1998). Granulocyte colony-stimulating factor in the combination chemotherapy for adult T-cell leukemia (ATL). Leuk. Lymphoma, 29, 407–414.
   PubMed Web of Science ®Google Scholar
• Sobue, R., Yamauchim, T. and Miyamura, K. (1987). Treatment of adult T cell leukemia with mega-dose cyclophosphamide and total body irradiation followed by allogeneic bone marrow transplantation. Bone Marrow Transplant, 2, 441–444.
   PubMed Web of Science ®Google Scholar
• Ljungman, P., Lawler, M., Asjo, B. et al. (1994). Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukemia. Br. J. Haematol., 88, 403–405.
   PubMed Web of Science ®Google Scholar
• Borg, A., Liu Yin, J. A., Johnson, P. R. E., Tosswill, J., Saunders, M. and Morris, D. (1996). Successful treatment of HTLV-1-associated acute adult T-cell leukemia lymphoma by allogeneic bone marrow transplantation. Br. J. Haematol., 94, 713–715.
   PubMed Web of Science ®Google Scholar
• Hande, K. R. and Garrow, G. C. (1996). Purine antimetabolites. In: Chabner, B. A. and Longo, D. L. Eds. Cancer chemotherapy and biotherapy: principles and practice. Philadelphia: Lippincott-Raven Publishers, pp. 235–252.
   Google Scholar
• Lofters, W., Campbell, M., Gibbs, W. N. and Cheson, B. D. (1987). 2-deoxycoformycin therapy in adult T-cell leukemia/lymphoma. Cancer, 60, 2605–2608.
   PubMed Web of Science ®Google Scholar
• Dearden, C., Matutes, E. and Catovsky, D. (1991). Deoxycoformycin in the treatment of mature T-cell leukemias. Br. J. Cancer, 64, 903–906.
   PubMed Web of Science ®Google Scholar
• Tobinai, K., Shimoyama, M., Inoue, S. et al. (1992). Phase I study of YK-176 (2-deoxycoformycin) in patients with adult T-cell leukemia lymphoma. Jpn. J. Clin. Oncol., 22, 164–171.
   PubMed Web of Science ®Google Scholar
• Tobinai, K., Ogura, M., Hotta, T. et al. (1997). Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Jpn. J. Clin. Oncol., 27, 146–153.
   PubMed Web of Science ®Google Scholar
• Tsuda, H., Takatsuki, K., Ohno, R. et al. (1994). Treatment of adult T-cell leukemia-lymphoma with irinotecan hydrochloride (CPT-11). Br. J. Cancer, 70, 775–777.
   PubMed Web of Science ®Google Scholar
• Andoh, T. (1998). Bis (2,6-dioxopiperazines), catalytic inhibitors of DNA topoisomerase II, as molecular probes, cardioprotectors and antitumor drugs. Biochimie, 80, 235–246.
   PubMed Web of Science ®Google Scholar
• Ohno, R., Masaoka, T., Shirakawa, S. et al. (1993). Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis (2,6-dioxopiperazine). The MST-16 Study Group. Cancer, 71, 2217–2221.
   PubMed Web of Science ®Google Scholar
• Witt, P. L., Linduer, D. J., D'Cunha, J. and Borden, E. C. (1996). Pharmacology of interferons: induced proteins, cell activation, and antitumor activity. In: Chabner, B. A. and Longo, D. L. Eds. Cancer chemotherapy and biotherapy: principles and practice. Philadelphia: Lippincott-Raven Publishers, pp. 585–607.
   Google Scholar
• Oka, T., Ohtsuki, Y., Sonobe, H., Furihata, M. and Miyoshi, I. (1990). Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I). Arch. Virol., 115, 63–73.
   PubMed Web of Science ®Google Scholar
• Tamura, K., Makino, S., Araki, Y., Imamura, T. and Seita, M. (1987). Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia. Cancer, 59, 1059–1062.
   PubMed Web of Science ®Google Scholar
• Gill, P. S., Harrington, W., Kaplan, M. H. et al. (1995). Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N. Eng. J. Med., 332, 1744–1748.
   PubMed Web of Science ®Google Scholar
• Hermine, O., Bouscary, D., Gessain, A. et al. (1995). Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N. Eng. J. Med., 332, 1749–1751.
   PubMed Web of Science ®Google Scholar
• Waldmann, T. A. (1994). Lymphokine receptors: a target for immunotherapy of lymphomas. Ann. Oncol., 5, Suppl 1, 13–17.
   PubMed Web of Science ®Google Scholar
• Waldmann, T. A. (1994). Anti-IL-2 receptor monoclonal antibody (Anti-Tac) treatment of T-cell lymphoma. Important Adv. Oncol., 131–141.
   Google Scholar
• Waldmann, T. A., White, J. D., Carrasquillo, J. A. et al. (1995). Radioimmunotherapy of interleukin-2Rαexpressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood, 86, 4063–4075.
   PubMed Web of Science ®Google Scholar
• Waldmann, T. A. (1995). Human T-cell lymphotropic virus typel-associated adult T-cell leukemia. JAMA, 273, 735–737.
   PubMed Web of Science ®Google Scholar
• Hino, S., Katamine, S., Migata, H., Tsuji, Y., Yamabe, T. and Miyamoto, T. (1996). Primary prevention of HTLV-I in Japan. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 13, Suppl 1, S199–S203.
   PubMedGoogle Scholar
• Nyambi, P. N., Ville, Y., Louwgie, J. et al. (1996). Mother-to child transmission of human T-cell lymphotropic virus types I and II (HTLV-I) in Gabon: a prospective follow-up of 4 years. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 12, 187–192.
   PubMedGoogle Scholar
• Kaplan, J. E., Khabbaz, R. F., Murphy, E. L. et al. (1996). Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 12, 193–201.
   PubMedGoogle Scholar
• Okochi, K., Sato, H. and Hinuma, Y. (1984). A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang., 46, 245–253.
   PubMed Web of Science ®Google Scholar
• Takezaki, T., Tajima, K., Ito, M. et al. (1997). Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I. Leukemia, 11, Suppl 3, 60–62.
   PubMedGoogle Scholar
• Melbye, M., Poulsen, A.-G., Gallo, D. et al. (1998). HTLV-1 infection in a population-based cohort of older persons in Guinea-Nissau, West Africa: risk factors and impact on survival. Int. J. Cancer, 76, 293–298.
   PubMed Web of Science ®Google Scholar
• Canavaggio, M., Leckie, G., Allain, J. P. et al. (1990). The prevalence of antibody to HTLV-I/II in United States plasma donors and in United States and French hemophiliacs. Transfusion, 30, 780–782.
   PubMed Web of Science ®Google Scholar
• Osame, M., Izumo, S., Igata, A. et al. (1986). Blood transfusion and HTLV-I associated myelopathy. Lancet, 2, 104–105.
   PubMed Web of Science ®Google Scholar
• Chen, Y.-C., Wang, C.-H., Su, I. J. et al. (1989). Infection of human T-cell leukemia virus type I and development of human T-cell leukemia/lymphoma in patients with hematologic neoplasms: a possible linkage of blood transfusion. Blood, 74, 388–394.
   PubMed Web of Science ®Google Scholar